Congratulations to Kevin Johansen and the very talented team who executed the Angel Capital Summit yesterday. What an incredible turnout of sophisticated angel investors. I believe in excess of 40 companies presented, naturally I stuck to the bio-track and was not disappointed.
Several Fitzsimons BioBusiness Partners related entities presented to packed rooms and were unable to address all of the questions within the allotted time periods. I’ll take that as a sign of if nothing else a keen interest in the featured technologies.
Take a look at who presented:
- a next generation bio-prosthetic foot
- a tissue heart valve and percutaneously-exchangeable leaflet set
- soft-tissue substitute for use in mucogingival surgeries
- an exo-muscular system for neuromotor and postural training
If you enjoyed this post get free email updates (here).